Probable risk factors of internal jugular vein stenosis in Chinese patients-A real-world cohort study

被引:6
|
作者
Bai, Chaobo [1 ,3 ,4 ]
Ding, Jiayue [1 ,3 ,4 ]
Zhou, Da [1 ,3 ,4 ]
Sun, Jingkun [1 ,3 ,4 ]
Liu, Cheng [1 ]
Pan, Liqun [1 ,3 ,4 ]
Ya, Jingyuan [1 ,3 ,4 ]
Wang, Zhongao [1 ,3 ,4 ]
Guan, Jingwei [1 ,3 ,4 ]
Jin, Kexin [1 ,3 ,4 ]
Ding, Yuchuan [4 ,5 ]
Ji, Xunming [2 ,3 ,4 ]
Ding, Jianping [1 ]
Meng, Ran [1 ,3 ,4 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China
[3] Beijing Inst Brain Disorders, Adv Ctr Stroke, Beijing, Peoples R China
[4] Capital Med Univ, Xuanwu Hosp, Dept China Amer Inst Neurosci, Beijing, Peoples R China
[5] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA
基金
国家重点研发计划;
关键词
Internal jugular vein stenosis; Contrast-enhanced magnetic resonance venography; Previous hepatitis B virus infection; Osseous; CEREBROSPINAL VENOUS INSUFFICIENCY; INTRACRANIAL HYPERTENSION; CIGARETTE-SMOKING; HEPATITIS-B; THROMBOSIS; DISEASE; HISTORY; ABNORMALITIES;
D O I
10.1016/j.clineuro.2020.105678
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Extracranial venous anomalies, especially internal jugular vein stenosis (IJVS), have recently received increasing attention, however, its etiologies are uncertain. This study aimed to explore the probable risk factors of IJVS in Chinese Patients and methods: Eligible patients with IJVS confirmed by contrast-enhanced magnetic resonance venography (CE-MRV) were enrolled from October 2017 through October 2018. Probable risk factors were analyzed, including the conditions that may result in IJV wall damage, extraluminal compression, gender and age. Results: A total of 133 patients enrolled in the final analysis, including 73 females and 60 males, the mean age were 54.83 +/- 15.25 years. In this IJVS cohort, the top two risks were previous hepatitis B virus (HBV) infection (48.9 %) and osseous compression (41.4 %). The IJVS cohort was divided into two subsets: extraluminal compression and non-compression. In the former, osseous compression (80.9 %) was the top risk factor, other risks including arterial (22.1 %) and lymph node compression (2.9 %). While, in the latter subset, the most common risk factor was previous HBV infection (46.2 %). In addition, cerebral venous sinus thrombosis (CVST) in non-compression subset was more common than that in extraluminal compression subset (21.5 % VS. 2.9 %, p= 0.001). When considered the gender (Male vs. Female), the ratios were 28.3 % vs. 0 % of smoking, p < 0.001, 16.67 % vs. 1.37 % of hyperhomocysteinemia, p= 0.002, and 11.67 % vs. 1.37 % of hyperuricemia, p= 0.023. In the subset with age less than 45 years, the top three risks included CVST (56.25 %), immunological diseases (55.56 %), and hyperhomocysteinemia (50.00 %), while, in the subset with the ages over 60 years, type2 diabetes (66.66 %), carotid artery compression (53.33 %), previous HBV infection (52.31 %), and osseous compression (49.09 %) were more common than others. Conclusion: This study illustrates the probable risks of IJVS may be diverse, in which osseous compression and previous HBV infection may be the top two probable risks of IJVS in Chinese. This is the biggest difference from previous reports based on Caucasian.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Probable factors affecting clinical outcomes of internal jugular vein stenosis
    Bai, Chaobo
    Wang, Zhongao
    Guan, Jingwei
    Jin, Kexin
    Sun, Jingkun
    Ding, Yuchuan
    Ji, Xunming
    Meng, Ran
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [2] Risk Factors Related to Severity in COVID-19 Patients: A Real-world Retrospective Cohort Study
    Kawaji, Hiromichi
    Kishimoto, Nobuhito
    Muguruma, Naoki
    Kozai, Hiroyuki
    Horiuchi, Noriaki
    INTERNAL MEDICINE, 2023, 62 (18) : 2627 - 2634
  • [3] Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study
    Brito-Zeron, Pilar
    Flores-Chavez, Alejandra
    Horvath, Ildiko Fanny
    Rasmussen, Astrid
    Li, Xiaomei
    Olsson, Peter
    Vissink, Arjan
    Priori, Roberta
    Armagan, Berkan
    Hernandez-Molina, Gabriela
    Praprotnik, Sonja
    Quartuccio, Luca
    Inanc, Nevsun
    Ozkiziltas, Burcugul
    Bartoloni, Elena
    Sebastian, Agata
    Romao, Vasco C.
    Solans, Roser
    Pasoto, Sandra G.
    Rischmueller, Maureen
    Galisteo, Carlos
    Suzuki, Yasunori
    Trevisani, Virginia Fernandes Moca
    Fugmann, Cecilia
    Gonzalez-Garcia, Andres
    Carubbi, Francesco
    Jurcut, Ciprian
    Shimizu, Toshimasa
    Retamozo, Soledad
    Atzeni, Fabiola
    Hofauer, Benedikt
    Melchor-Diaz, Sheila
    Gheita, Tamer
    Lopez-Dupla, Miguel
    Fonseca-Aizpuru, Eva
    Giacomelli, Roberto
    Vazquez, Marcos
    Consani, Sandra
    Akasbi, Miriam
    Nakamura, Hideki
    Szanto, Antonia
    Farris, A. Darise
    Wang, Li
    Mandl, Thomas
    Gattamelata, Angelica
    Kilic, Levent
    Pirkmajer, Katja Perdan
    Abacar, Kerem
    Tufan, Abdurrahman
    de Vita, Salvatore
    ECLINICALMEDICINE, 2023, 61
  • [4] A real-world study of Alemtuzumab in a cohort of Italian patients
    Sacca, F.
    Russo, C. V.
    Frau, J.
    Annovazzi, P.
    Signoriello, E.
    Bonavita, S.
    Grasso, R.
    Clerico, M.
    Cordioli, C.
    Laroni, A.
    Capobianco, M.
    Clerici, V. Torri
    Sartori, A.
    Cavalla, P.
    Maniscalco, G. T.
    La Gioia, S.
    Caleri, F.
    Giugno, A.
    Iodice, R.
    Carotenuto, A.
    Cocco, E.
    Fenu, G.
    Zaffaroni, M.
    Baronicini, D.
    Lus, G.
    Gallo, A.
    De Mercanti, S. F.
    Lapucci, C.
    Di Francescantonio, V.
    Sormani, M. P.
    Signori, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 796 - 797
  • [5] A real-world study of alemtuzumab in a cohort of Italian patients
    Russo, Cinzia Valeria
    Sacca, Francesco
    Frau, Jessica
    Annovazzi, Pietro
    Signoriello, Elisabetta
    Bonavita, Simona
    Grasso, Roberta
    Clerico, Marinella
    Cordioli, Cinzia
    Laroni, Alice
    Capobianco, Marco
    Clerici, Valentina Torri
    Sartori, Arianna
    Cavalla, Paola
    Maniscalco, Giorgia Teresa
    La Gioia, Sara
    Caleri, Francesca
    Giugno, Alessia
    Iodice, Rosa
    Carotenuto, Antonio
    Cocco, Eleonora
    Fenu, Giuseppe
    Zaffaroni, Mauro
    Baroncini, Damiano
    Lus, Giacomo
    Gallo, Antonio
    De Mercanti, Stefania Federica
    Lapucci, Caterina
    Di Francescantonio, Valeria
    Brambilla, Laura
    Sormani, Maria Pia
    Signori, Alessio
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (01) : 257 - 266
  • [6] Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study
    Li, Yan Kiu
    Guo, Chuan-Guo
    Cheung, Ka Shing
    Liu, Kevin S. H.
    Leung, Wai K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (12) : 3051 - 3059
  • [7] Real-world Study of the Incidence and Risk Factors of Venous Thromboembolism in Chinese Lung Cancer (RIVAL)
    Wang, Z.
    Lin, Z. -B.
    Tu, H. -Y.
    Zhou, Q.
    Xu, B. -F.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S504 - S504
  • [8] A Retrospective Study Comparison Between Stenting and Standardized Medical Treatment for Intracranial Vertebrobasilar Stenosis in a Real-World Chinese Cohort
    Li, Guanzeng
    Yan, Peng
    Zhao, Yuanyuan
    Li, Shan
    Xue, Yuan
    Xiang, Yuanyuan
    Liu, Xiaohui
    Li, Jifeng
    Sun, Qinjian
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [9] Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study
    Gyldenlove, Mette
    Nissen, Christoffer Valdemar
    Stave, Sascha Dinsen Wreschner
    Thomsen, Simon Francis
    Egeberg, Alexander
    Loft, Nikolai
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (01) : 147 - 150
  • [10] Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry
    Ogdie, Alexis
    Harrison, Ryan W.
    McLean, Robert R.
    Lin, Tin-chi
    Lebwohl, Mark
    Strober, Bruce E.
    Zhuo, Joe
    Patel, Vardhaman
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1303 - 1311